Literature DB >> 29656209

Phosphorylation of low density lipoprotein receptor-related protein 6 is involved in receptor for advanced glycation end product-mediated β-catenin stabilization in a toluene diisocyanate-induced asthma model.

Jing Xiong1, Wenqu Zhao1, Yun Lin1, Lihong Yao1, Guohua Huang1, Changhui Yu1, Hangming Dong1, Guanhua Xiao1, Haijin Zhao2, Shaoxi Cai3.   

Abstract

BACKGROUND: We have previously demonstrated that the receptor for advanced glycation end products (RAGE)/β-catenin axis plays a vital role in regulating airway inflammation and airway remodeling in a toluene diisocyanate (TDI)-induced murine asthma model. However, the exact mechanism of β-catenin activation remains unclear. Given that phosphorylation of the low-density lipoprotein receptor-related protein 6 (Lrp6) is a key step in mediating β-catenin stabilization in canonical wnt/β-catenin signaling, we explored the possible relationship between RAGE and Lrp6 in regulating β-catenin stabilization in TDI-induced asthma.
METHODS: In this study, a TDI-induced murine asthma model was generated, and mice were treated with a specific inhibitor of RAGE. In vitro, the human bronchial epithelial cell line 16HBE was treated with TDI-human serum albumin (TDI-HSA). RAGE overexpression or knockdown cells were also constructed and assessed.
RESULTS: The results showed that RAGE inhibition or RAGE knockdown decreased β-catenin nuclear accumulation and the expression of relevant β-catenin targeted genes (VEGF, MMP9, TGF-β1) in the TDI-induced murine asthma model and TDI-HSA-treated 16HBE cells, respectively. Silencing of RAGE reversed the TDI-induced increase in phospho-ERK1/2 (p-ERK) and phospho-Lrp6 (p-Lrp6) in 16HBE cells. Pretreatment with the extracellular signal-regulated kinase (ERK)1/2 inhibitor U0126 suppressed TDI-induced Lrp6 phosphorylation. Furthermore, knockdown of Lrp6 in 16HBE cells decreased β-catenin nuclear translocation and the expression of VEGF, MMP9, and TGF-β1.
CONCLUSION: These data suggested that the RAGE/ERK axis modulates Lrp6 phosphorylation, contributing to β-catenin stabilization in a TDI-induced murine model.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asthma; Low density lipoprotein receptor-related protein 6; Receptor for advanced glycation end product; Toluene diisocyanate; β-catenin

Mesh:

Substances:

Year:  2018        PMID: 29656209     DOI: 10.1016/j.intimp.2018.03.037

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  miR-3934 regulates the apoptosis and secretion of inflammatory cytokines of basophils via targeting RAGE in asthma.

Authors:  Liyan Dou; Wenyu Wang; Junwei Wang; Xiaofei Zhang; Xiaoman Hu; Weili Zheng; Kaiyu Han; Guangyou Wang
Journal:  Allergy Asthma Clin Immunol       Date:  2022-08-04       Impact factor: 3.373

2.  Association of RAGE gene multiple variants with the risk for COPD and asthma in northern Han Chinese.

Authors:  Hongtao Niu; Wenquan Niu; Tao Yu; Feng Dong; Ke Huang; Ruirui Duan; Shiwei Qumu; Minya Lu; Yong Li; Ting Yang; Chen Wang
Journal:  Aging (Albany NY)       Date:  2019-05-29       Impact factor: 5.682

3.  Consistent Biomarkers and Related Pathogenesis Underlying Asthma Revealed by Systems Biology Approach.

Authors:  Xiner Nie; Jinyi Wei; Youjin Hao; Jingxin Tao; Yinghong Li; Mingwei Liu; Boying Xu; Bo Li
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

4.  RAGE mediates airway inflammation via the HDAC1 pathway in a toluene diisocyanate-induced murine asthma model.

Authors:  Xianru Peng; Minyu Huang; Wenqu Zhao; Zihan Lan; Xiaohua Wang; Yafei Yuan; Bohou Li; Changhui Yu; Laiyu Liu; Hangming Dong; Shaoxi Cai; Haijin Zhao
Journal:  BMC Pulm Med       Date:  2022-02-11       Impact factor: 3.317

5.  Using high-throughput metabolomics to discover perturbed metabolic pathways and biomarkers of allergic rhinitis as potential targets to reveal the effects and mechanism of geniposide.

Authors:  Yan-Li Zhang; Peng-Cheng Yu; Peng Liu
Journal:  RSC Adv       Date:  2019-06-04       Impact factor: 4.036

6.  The AKT inhibitor MK2206 suppresses airway inflammation and the pro‑remodeling pathway in a TDI‑induced asthma mouse model.

Authors:  Haiyan Cui; Yuanxiong Cheng; Yi He; Weiying Cheng; Wenqu Zhao; Haijin Zhao; Fiona H Zhou; Liping Wang; Jianghui Dong; Shaoxi Cai
Journal:  Mol Med Rep       Date:  2020-08-21       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.